Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Vermont for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Vermont only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Vermont (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Gurpreet Lamba (NPI 1427294271)

Field	Value
Entity Type	Individual
Organization	Gurpreet Lamba
Address	89 Beaumont Ave
City	Burlington
State	VT
ZIP	05405
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	December 29, 2008

Payer Source	Total Paid
Medicare	$2.2M
Medicaid	$0

Key Findings

GURPREET LAMBA is effectively a Medicare-focused Hematology & Oncology physician with Total Medicare revenue of $2.2M and no Medicaid billing on file; this makes the provider functionally single-payer in available data, so payer-mix analysis should treat Medicare as the dominant revenue source. The NPI was enumerated 2008-12-29 (~18 years ago), indicating long-term presence in the market that can support established referral and treatment patterns.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 56.4% of this provider's total Medicare revenue, indicating the practice derives a majority of its Medicare income from a small set of drug and infusion services. The largest single code is J9144 (daratumumab with hyaluronidase) at $567.7K (25.8% of Medicare revenue), followed by J9299 (nivolumab) at $527K (23.9%), and J1569 (immune globulin) at $148.7K (6.7%), showing biologic/infusion therapies dominate billing.

Business and service-line implications from the top codes point to an infusion-centered oncology practice: high revenue from J9144 and J9299 suggests routine administration of high-cost monoclonal antibodies and immune checkpoint inhibitors, while significant activity in infusion/chemotherapy administration codes (96413, 96365, 96367) and E/M codes (99214, 99215) indicates both medical oncology infusion services and complex outpatient clinic visits. The presence of supportive-care injectables such as J1627 (granisetron) and J0885 (epoetin alfa) reinforces a full-spectrum oncology infusion service model including antiemetic and anemia management.

Competitive standing is mixed across codes: for J9144 this provider ranks #92 of 615 (85th percentile), and for J9299 ranks #139 of 505 (73rd percentile) — both reflect typical, unremarkable national volumes rather than market dominance, meaning the provider is a meaningful but not leading national contributor for these agents. In contrast, several E/M and infusion administration/service codes are extreme or notable outliers: 99233 ranks in the 99th percentile labeled an "extreme outlier, far above typical national volume," 99215 ranks in the 100th percentile as an "extreme outlier," and 96367 also ranks in the 99th percentile as an "extreme outlier," which together suggest unusually high intensity or volume of complex inpatient follow-ups, high-complexity office visits, and additional infusion administration relative to national peers.

Operational intensity is underscored by high-percentile E/M inpatient and outpatient codes: 99233 (1.2K claims, $123K revenue) and 99215 (749 claims, $109.4K revenue) are both described as extreme outliers or far above typical national volume, implying the provider manages a large number of complex inpatient follow-up encounters and high-complexity outpatient visits. This pattern could reflect a patient panel with high acuity, a regional referral role for complex oncology cases, or a practice model emphasizing frequent, lengthy visits.

Procedure-level volume shows routine supportive and procedural work consistent with oncology infusion clinics: high claim counts for drug administration codes (for example, J0185 15.2K claims, J1627 9.3K claims) and procedures like 36415 (2.2K claims for blood draws) and 85025 (2.1K claims for CBCs) indicate substantial ancillary services tied to infusion workflows, such as lab monitoring and antiemetic support. These ancillary code volumes support the business view that infusion therapy and its associated supportive care are central to daily operations.

Absence of Medicaid activity is material: with no Medicaid billing on file, the practice will not appear in Medicaid-driven network or utilization analyses and is unlikely to be impacted by Medicaid rate changes or managed-Medicaid contracting in Vermont. For payer strategy or network design, this provider should be treated as a Medicare-centric partner unless downstream data later shows Medicaid engagement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

43 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	14,940	$40	$567.7K
J9299	Injection, nivolumab, 1 mg	21,960	$20	$527K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	4,130	$40	$148.7K
J0897	Injection, denosumab, 1 mg	7,800	$20	$148.2K
99233	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	1,240	$100	$123K
J1437	Injection, ferric derisomaltose, 10 mg	7,300	$20	$116.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	750	$150	$109.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	870	$100	$88.9K
J1627	Injection, granisetron, extended-release, 0.1 mg	9,300	$10	$46.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	370	$110	$42.6K

Showing 1–10 of 43

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 43 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Vermont Distribution

Gurpreet Lamba — 14 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Vermont

Full comparison — all codes billed, vs. state median

43 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9144	1	10	14,940	$40	$565.1K
J9299	1	10	21,960	$20	$519.2K
J1569	1	10	4,130	$40	$147.8K
J0897	1	10	7,020	$20	$130.2K
J1437	1	10	7,300	$20	$118.9K
J1627	1	10	9,300	$1	$42.9K
96413	3	10	390	$110	$34.1K
J0885	1	10	4,930	$10	$28.1K
Q5106	1	10	4,060	$10	$24.8K
J0185	1	10	15,210	$1	$20.9K

Showing 1–10 of 43

Related Providers

Other providers that share a Tax Identification Number (TIN) with Gurpreet Lamba, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Glen Gejerman	NJ	Radiation Oncology Physician	$6.5M	$0
Bhavesh Balar	NJ	Hematology & Oncology Physician	$4.2M	$0
Kenneth Nahum	NJ	Hematology & Oncology Physician	$3.2M	$0
Frederick Smith	MD	Medical Oncology Physician	$2.7M	$0
May Abdo-matkiwsky	NJ	Hematology & Oncology Physician	$2.6M	$0
Denis Fitzgerald	NJ	Hematology & Oncology Physician	$2.3M	$0
Jeffrey Silberberg	NJ	Hematology & Oncology Physician	$2M	$0
Victor Aviles	MA	Hematology & Oncology Physician	$1.8M	$0
James Xu	MD	Hematology & Oncology Physician	$1.6M	$0
Jaffar Hilli	MO	Hematology & Oncology Physician	$1.6M	$0

Nearby Providers

Other providers in the same ZIP code as Gurpreet Lamba, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Vermont And State Agricultural College	VT	Land Ambulance	$184.1K	$470.4K
Vermont Psychological Services: Leitenberg Center For Evidence-based P	VT	Clinical Psychologist	$0	$128.1K
Amer Abu Alfa	VT	Anatomic Pathology & Clinical Pathology Physician	$68.1K	$0
Julian Sprague	VT	Hematology (Internal Medicine) Physician	$55.4K	$0
John Taylor	VT	Neurology Physician	$49.2K	$0
Michelle Sowden	VT	Surgery Physician	$35.1K	$0
Charles Kinsey	VT	Pulmonary Disease Physician	$20.7K	$0
Daniel Weiss	VT	Pulmonary Disease Physician	$14.7K	$0
Corey Enfanto	VT	Audiologist	$3.4K	$0
Michael Kem	VT	Anesthesiology Physician	$1.5K	$0

Gurpreet Lamba — Billing Profile & Reimbursement Data

Sign up for Gurpreet Lamba — Billing Profile & Reimbursement Data policy alerts

Gurpreet Lamba — Billing Profile & Reimbursement Data

Sign up for Gurpreet Lamba — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References